Perennial buying up after offloading a few months after IPO.
Caledonia also have near 10% and they are a solid long term backer with experience in tech and Telehealth.
Europe coming out of COVID, DOC’s core value will shine bringing together primary and secondary care. Further Margins are in secondary care and diagnostics throughout the patient journey.
I have been adding more DOC to my portfolio, strong growth trajectory ahead and momentum.
Perennial buying up after offloading a few months after IPO....
Add DOC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
-0.002(3.23%) |
Mkt cap ! $21.99M | |||
| Open | High | Low | Value | Volume |
| 6.2¢ | 6.2¢ | 6.0¢ | $14.90K | 243.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 272500 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 92273 | 2 |
View Market Depth
| Last trade - 12.42pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.2¢ |
Change
-0.002 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 6.1¢ | 6.2¢ | 6.1¢ | 28314 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| DOC (ASX) Chart |